GranuFlo Dialysis Cardiac Arrest

September 2, 2012

Two products manufactured by Fresenius Medical Care have been recalled after being linked to increased risk of cardiac arrest and death. The products are:

  • GranuFlo Dry Acid Concentrate
  • NaturaLyte Liquid Acid Concentrate

When administered incorrectly, both products elevate the bicarbonate levels in a patient’s body much higher than normal levels, which can result in severe health consequences and even death. Lawsuit claims have been filed against Fresenius Medical care in response to GranuFlo cardiac; the company is also alleged of having knowledge of these adverse health consequences and side effects and only making this information available to employees of FMC.

GranuFlo Dialysis Side Effects

The popular dialysis solution products GranuFlu and NaturaLyte are both manufactured by the company Fresenius Medical Care and both have been linked to a range of serious side effects, including cardiac arrest.  Because of these serious GranuFlo dialysis side effect and deaths, the United States Food and Drug Administered a class I recall of both FMC products. Class I recall is the most serious FDA recall and is reserved to remove products from the market that cause adverse health consequences and/or deaths to consumers. GranuFlo Dialysis solution has demonstrated increased risk of metabolic alkalosis, which can lead to the following GranuFlo side effects:

  • Low Blood Pressure
  • Hypercapnia
  • Hypokalemia
  • Hypoxemia
  • Cardiac Arrhythmia
  • Cardiac Arrest/ Cardiopulmonary Arrest
  • Death

Granuflo Cardiac Arrest Cover Up

In the fall of 2011, a company memo of Fresenius Medical Care made it clear that they were aware of the increased risk of heart attacks and death when GranuFlo was not administered in the proper doses. This memo suggested that the risk of cardiac arrest was increased as much as six times in these circumstances. It is also alleged that 941 patients treated with these dialysis products experienced cardiac arrest/heart attack between January and December of 2010. This information was only sent to doctors employed by Fresenius‘s own dialysis treatment centers. However, the company also sells its products for use in other treatment locations¸ which did not receive any such warning.

Harmed By GranuFlo? Speak with an Attorney

Did you or a loved one experience cardiac arrest after treatment with GranuFlo Dry Acid Concentrate or NaturaLyte Liquid Acid Concentrate? If so, call the Willis Law Firm today because you may have a potential dialysis side effect lawsuit. When you call, we will provide you with the information you need in order to decide whether filing a GranuFlo lawsuit is the right choice for you. All dialysis cardiac arrest clients are represented on a fee contingent basis, which means you will not be billed unless a recovery is made in your favor. Don’t delay; let us help you today!

© Willis Law Firm for Drug Attorneys. Replication strictly prohibited without written consent.